Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVP
3001
DELISTED
Avon Products, Inc.
AVP
| $1.74M | ﹤0.01% |
791,549
-220,886
| -22% | -$407K |
|
3002
Usana Health Sciences
USNA
$253M
| $1.74M | ﹤0.01% |
14,443
+6,427
| +80% | +$798K |
|
3003
CALL
Allstate
ALL
$65.3B
| $1.74M | ﹤0.01% |
17,600
-21,300
| -55% | -$2.08M |
|
3004
Corcept Therapeutics
CORT
$12.1B
| $1.74M | ﹤0.01% |
123,887
+85,571
| +223% | +$1.2M |
|
3005
Western Alliance Bancorporation
WAL
$8.98B
| $1.74M | ﹤0.01% |
30,513
-11,857
| -28% | -$683K |
|
|
ESL
3006
DELISTED
Esterline Technologies
ESL
| $1.73M | ﹤0.01% |
19,034
+16,664
| +703% | +$1.4M |
|
3007
Gibraltar Industries
ROCK
$1.47B
| $1.73M | ﹤0.01% |
37,881
+21,590
| +133% | +$934K |
|
|
DOOR
3008
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.73M | ﹤0.01% |
26,905
+1,591
| +6% | +$109K |
|
3009
CALL
SM Energy
SM
$7.62B
| $1.72M | ﹤0.01% |
54,600
-11,100
| -17% | -$319K |
|
|
WES
3010
PUT
DELISTED
Western Gas Partners Lp
WES
| $1.72M | ﹤0.01% |
+39,400
| New | +$1.95M |
|
|
CSGS
3011
DELISTED
CSG Systems International
CSGS
| $1.72M | ﹤0.01% |
42,808
+10,020
| +31% | +$396K |
|
|
BAND
3012
Bandwidth Inc
BAND
$1.73B
| $1.72M | ﹤0.01% |
32,066
+25,798
| +412% | +$1.14M |
|
3013
LivePerson
LPSN
$34.3M
| $1.72M | ﹤0.01% |
4,414
+2,017
| +84% | +$744K |
|
|
WRD
3014
DELISTED
WildHorse Resource Development
WRD
| $1.72M | ﹤0.01% |
72,701
-3,552
| -5% | -$76.3K |
|
|
EFII
3015
DELISTED
Electronics for Imaging
EFII
| $1.72M | ﹤0.01% |
50,420
+30,945
| +159% | +$1.05M |
|
|
AMWD
3016
DELISTED
American Woodmark
AMWD
| $1.72M | ﹤0.01% |
21,877
+4,570
| +26% | +$390K |
|
3017
Associated Banc-Corp
ASB
$6.08B
| $1.72M | ﹤0.01% |
65,984
+56,433
| +591% | +$1.54M |
|
3018
TORM
TRMD
$3.02B
| $1.72M | ﹤0.01% |
259,910
-101,236
| -28% | -$697K |
|
|
ABB
3019
DELISTED
ABB Ltd
ABB
| $1.72M | ﹤0.01% |
72,561
+24,379
| +51% | +$559K |
|
3020
PUT
QuidelOrtho
QDEL
$1.02B
| $1.71M | ﹤0.01% |
+26,300
| New | +$1.84M |
|
3021
CALL
Vulcan Materials
VMC
$36.2B
| $1.71M | ﹤0.01% |
15,400
-9,200
| -37% | -$1.07M |
|
3022
PUT
Jabil
JBL
$39.1B
| $1.71M | ﹤0.01% |
63,200
+28,100
| +80% | +$805K |
|
3023
CALL
Murphy USA
MUSA
$10.2B
| $1.71M | ﹤0.01% |
+20,000
| New | +$1.65M |
|
3024
CALL
Novartis
NVS
$289B
| $1.71M | ﹤0.01% |
22,097
-20,423
| -48% | -$1.51M |
|
3025
News Corp Class B
NWS
$17.7B
| $1.7M | ﹤0.01% |
125,193
-41,782
| -25% | -$601K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.